TRIM69 and neoplasm: Subsequently, tumor and paraneoplastic tissues from COAD patients collected during clinical consultation were subjected to real-time quantitative reverse transcription PCR (RT-qPCR) analysis and immunohistochemistry to detect TRIM69 expression at different levels.